SYV_NANEQ
ID SYV_NANEQ Reviewed; 751 AA.
AC Q74NF3;
DT 07-MAR-2006, integrated into UniProtKB/Swiss-Prot.
DT 05-JUL-2004, sequence version 1.
DT 03-AUG-2022, entry version 95.
DE RecName: Full=Valine--tRNA ligase;
DE EC=6.1.1.9;
DE AltName: Full=Valyl-tRNA synthetase;
DE Short=ValRS;
GN Name=valS; OrderedLocusNames=NEQ252;
OS Nanoarchaeum equitans (strain Kin4-M).
OC Archaea; Nanoarchaeota; Candidatus Nanoarchaeia; Nanoarchaeales;
OC Nanoarchaeaceae; Nanoarchaeum.
OX NCBI_TaxID=228908;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=Kin4-M;
RX PubMed=14566062; DOI=10.1073/pnas.1735403100;
RA Waters E., Hohn M.J., Ahel I., Graham D.E., Adams M.D., Barnstead M.,
RA Beeson K.Y., Bibbs L., Bolanos R., Keller M., Kretz K., Lin X., Mathur E.,
RA Ni J., Podar M., Richardson T., Sutton G.G., Simon M., Soell D.,
RA Stetter K.O., Short J.M., Noorderwier M.;
RT "The genome of Nanoarchaeum equitans: insights into early archaeal
RT evolution and derived parasitism.";
RL Proc. Natl. Acad. Sci. U.S.A. 100:12984-12988(2003).
CC -!- FUNCTION: Catalyzes the attachment of valine to tRNA(Val). As ValRS can
CC inadvertently accommodate and process structurally similar amino acids
CC such as threonine, to avoid such errors, it has a 'posttransfer'
CC editing activity that hydrolyzes mischarged Thr-tRNA(Val) in a tRNA-
CC dependent manner (By similarity). {ECO:0000250}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=ATP + L-valine + tRNA(Val) = AMP + diphosphate + L-valyl-
CC tRNA(Val); Xref=Rhea:RHEA:10704, Rhea:RHEA-COMP:9672, Rhea:RHEA-
CC COMP:9708, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57762,
CC ChEBI:CHEBI:78442, ChEBI:CHEBI:78537, ChEBI:CHEBI:456215; EC=6.1.1.9;
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC -!- DOMAIN: ValRS has two distinct active sites: one for aminoacylation and
CC one for editing. The misactivated threonine is translocated from the
CC active site to the editing site (By similarity). {ECO:0000250}.
CC -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase family.
CC ValS type 2 subfamily. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AE017199; AAR39104.1; -; Genomic_DNA.
DR AlphaFoldDB; Q74NF3; -.
DR SMR; Q74NF3; -.
DR STRING; 228908.NEQ252; -.
DR EnsemblBacteria; AAR39104; AAR39104; NEQ252.
DR KEGG; neq:NEQ252; -.
DR PATRIC; fig|228908.8.peg.256; -.
DR HOGENOM; CLU_001493_0_2_2; -.
DR OMA; FATKLWN; -.
DR Proteomes; UP000000578; Chromosome.
DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR GO; GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro.
DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR GO; GO:0004832; F:valine-tRNA ligase activity; IEA:UniProtKB-EC.
DR GO; GO:0006438; P:valyl-tRNA aminoacylation; IEA:InterPro.
DR CDD; cd07962; Anticodon_Ia_Val; 1.
DR Gene3D; 3.40.50.620; -; 2.
DR InterPro; IPR002300; aa-tRNA-synth_Ia.
DR InterPro; IPR033705; Anticodon_Ia_Val.
DR InterPro; IPR013155; M/V/L/I-tRNA-synth_anticd-bd.
DR InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR InterPro; IPR009008; Val/Leu/Ile-tRNA-synth_edit.
DR InterPro; IPR002303; Valyl-tRNA_ligase.
DR PANTHER; PTHR11946; PTHR11946; 1.
DR Pfam; PF08264; Anticodon_1; 1.
DR Pfam; PF00133; tRNA-synt_1; 1.
DR PRINTS; PR00986; TRNASYNTHVAL.
DR SUPFAM; SSF47323; SSF47323; 1.
DR SUPFAM; SSF50677; SSF50677; 1.
PE 3: Inferred from homology;
KW Aminoacyl-tRNA synthetase; ATP-binding; Cytoplasm; Ligase;
KW Nucleotide-binding; Protein biosynthesis; Reference proteome.
FT CHAIN 1..751
FT /note="Valine--tRNA ligase"
FT /id="PRO_0000224628"
FT BINDING 520
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000250"
SQ SEQUENCE 751 AA; 89618 MW; 790A1BFF847BBEBC CRC64;
MPYNPKEIEQ WYKENYKYFF GEGDKILIID TPPPYPAPLW HIGAALSYAL QDFIARGFRK
LGYKVIFPEG FDGNGIPIEM YLEKYEKIPF GSIDREEYIK KCRQILDSWR EKMDKILKDL
LLSMDFEHRY NTDDPEYRAL TQKTFAELWE KGLIYEAEYP INYCPHCKTA IADAEIERKI
KKTKLVYIKF KIKDSDDYIT VATTRPELLG ACKAIIVHPD DERYKKYHNK IAIVPYYNRE
IPIIPHKMAD PNFGTGAVMI CSYGDWVDVQ IFRELQLKPE KIIDENGRLT IEPVKGLTTK
EGREKMIEVL KQLGVVEKIE EIEHSVPVHE RCETEIEIIP MKEFYLKQLP FKEEIKKLSK
EIEFIPERYR KNLENWIDSI TIDWPISRRR WYATEIPLWY CPKCGYIHVA KDGKYHQPWK
EEMVCPRCNT KMVGETRVLD TWMDSSITIY YLIKKYSKIL GIDEEGLFNN YTLRPQGYEI
IRTWLYYTLL RVYQLTGKKA FDFVVINGMG LDKHGRKMSK RYGNVIEPET LLEKYGADTL
RYWFAMEISI GEDYRINEQK IAGIMKFMNK VWNIANYISQ YQYRETQNLK PTDEWIINYV
KYLENKAIEY IRNFEFNKLA RELYRFVWDV FANHYIELTK KRAKNNDDSA IYALYFVFER
VLNMLSIFSP GIAKYLAKKL YNKDIEKEKL KYWGKVRLDL LYKGEKLIEF NNYVWKLKTS
QGKKLKDPIS IEIPKELEIF KEDLILLHNI Q